First author Hayden Malone, St. Jude Graduate School of Biomedical Sciences and corresponding author Charles W. M. Roberts, MD, PhD, Executive Vice President, and St. Jude Comprehensive Cancer Center ...
Hosted on MSN
Scientists uncover previously unknown chromatin regulation mechanism with therapeutic potential for pediatric cancer
As many as 1 in 4 cancers are driven by mutations in the SWI/SNF chromatin-remodeling complex, which controls access to DNA. A study led by St. Jude Children's Research Hospital recently identified ...
The FIPO23 trial: First-in-human phase I/II study of XON7 in advanced solids tumors. ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in ...
A collaborative team led by Bing Li from Shanghai Jiao Tong University School of Medicine published an article titled "BCL7A’s arginine anchor links nucleosome recognition to chromatin remodeling and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results